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SUBJECTS: 




In an effort to understand the reaction mechanism of a B2 metallo-β-lactamase, steady-state and pre-steady-
state kinetic and rapid freeze quench electron paramagnetic resonance (EPR) studies were conducted on ImiS 
and its reaction with imipenem and meropenem. pH dependence studies revealed no inflection points in the pH 
range of 5.0−8.5, while proton inventories demonstrated at least 1 rate-limiting proton transfer. Site-directed 
mutagenesis studies revealed that Lys224 plays a catalytic role in ImiS, while the side chain of Asn233 does not 
play a role in binding or catalysis. Stopped-flow fluorescence studies on ImiS, which monitor changes in 
tryptophan fluorescence on the enzyme, and its reaction with imipenem and meropenem revealed biphasic 
fluorescence time courses with a rate of fluorescence loss of 160 s-1 and a slower rate of fluorescence regain of 
98 s-1. Stopped-flow UV−vis studies, which monitor the concentration of substrate, revealed a rapid loss in 
absorbance during catalysis with a rate of 97 s-1. These results suggest that the rate-limiting step in the reaction 
catalyzed by ImiS is C−N bond cleavage. Rapid freeze quench EPR studies on CoII-substituted ImiS demonstrated 
the appearance of a rhombic signal after 10 ms that is assigned to a reaction intermediate that has a five-
coordinate metal center. A distinct product (EP) complex was also observed and began to appear in 18−19 ms. 
When these results are taken together, they allow for a reaction mechanism to be offered for the B2 metallo-β-
lactamases and demonstrate that the mono- and dinuclear ZnII-containing enzymes share a common rate-
limiting step, which is C−N bond cleavage. 
 
Bacterial resistance to antibiotics is a growing clinical concern (1, 2). ZnII-containing β-lactamases (metallo-β-
lactamases, MβLs)1 contain 1−2 mol of ZnII/mol of enzyme, hydrolyze all known cephalosporins, carbapenems, 
and penicillins, are not inhibited by clavulanic acid and other classical β-lactamase inhibitors, and have no known 
clinically useful inhibitor toward them (3, 4). Previous studies have shown that there is significant structural and 
mechanistic diversity among the MβLs, leading to the grouping of the enzymes into three distinct subclasses:  
B1, B2, and B3 (5, 6). Sequence identity ranges from 25−40% between members in one subclass and from 
10−20% between members in different subclasses. Subclass B1 enzymes have been found in strains 
of Bacillus, Bacteroides, Pseudomonas, Serratia, and Chryseobacterium, and subclass B3 enzymes have been 
found in strains of Stenotrophomonas, Legionella, Fluoribacter, Janthinobacterium, and Caulobacter (3, 4). 
Enzymes from the B1 and B3 subclasses have broad substrate profiles and require two ZnII ions for maximal 
enzymatic activity (3). In contrast, subclass B2 enzymes have a relatively narrow substrate profile, hydrolyzing 
carbapenems almost exclusively (3), and exhibit maximal activity when bound to only 1 ZnII (7). In fact, the 
binding of a second ZnII ion is inhibitory (7). These carbapenemases are produced by various species 
of Aeromonas. Aeromonads are enteric, anaerobic, Gram-negative pathogens that cause a range of symptoms 
from mild diarrhea to acute gastroenteritis in humans (8), and Aeromonas species have been found in wound 
infections (9). One alarming characteristic of Aeromonads is that they are waterborne and typically are present 
in purified, drinking water (10). To date, there is no crystal structure available for ImiS, but the crystal structure 
of another subclass B2 enzyme, CphA from Aeromonas hydrophila, has been recently reported (11). This 
structure showed ZnII bound to His263, Cys221, Asp120, and a water; this site is the consensus Zn2 site in MβLs 
(3). Recent spectroscopic studies have demonstrated that ZnII/CoII preferentially binds to this same site in ImiS 
(12). Previous biochemical, kinetic, and inhibition studies have suggested significant structural and mechanistic 
differences among the different group B β-lactamases (3, 4, 13). These results suggest that one inhibitor may not 
be effective in treating all infections caused by bacteria that produce a MβL. Toney and Moloughney recently 
reviewed the literature on inhibitors of MβLs (13), and most of these inhibitors are effective against only one or 
two of the enzymes. This is not surprising because, with few exceptions (14−16), the design of most of the 
inhibitors was guided by studies on only one enzyme. To address this problem, we are currently characterizing a 
MβL from each of the group B subclasses (CcrA, ImiS, and L1) in an effort to identify common 
structural/mechanistic properties of the enzymes toward which a single inhibitor can be designed. While 
extensive mechanistic studies have been reported on B1 and B3 MβLs (17−24), there is little known about the 
mechanism of a B2 MβL. Herein, we describe the first detailed mechanistic studies on a B2 MβL, specifically ImiS 
from Aeromonas veronii bv. sobria. 
Experimental Procedures 
Preparation of ImiS Samples.  
Recombinant ImiS was prepared as described previously (25). Briefly, the overexpression plasmid, pET26b-ImiS, 
was used to transform BL21(DE3) Escherichia coli cells. A 10 mL overnight culture of these cells in Luria−Bertani 
(LB) medium was used to innoculate 4 × 1 L of LB medium containing 25 μg/mL kanamycin and 29 μg/mL 
ZnSO4·7H2O. The cells were allowed to grow at 37 °C with shaking until the cells reached an optical density at 
600 nm of 0.6−0.8. Protein production was induced with 1 mM isopropyl-β-d-thiogalactopyranoside (IPTG), and 
the cells were shaken at 37 °C for 3 h. The cells were collected by centrifugation (15 min at 7000g) and 
resuspended in 30 mL of 50 mM tris(hydroxymethyl)aminomethane (Tris) at pH 7.0 containing 500 mM NaCl. 
The cells were ruptured by two passages through a French press at 16 000 lb/in., and the cell debris was 
separated by centrifugation (30 min at 25000g). The cleared supernatant was dialyzed versus 2 L of 50 mM Tris 
at pH 7.0 overnight at 4 °C, centrifuged to remove insoluble matter, and loaded onto a SP-Sepharose column 
(1.5 × 12 cm with a 25 mL bed volume) that was equilibrated with 50 mM Tris at pH 7.0. Bound proteins were 
eluted with a 0−500 mM NaCl gradient in 50 mM Tris at pH 7.0 and 2 mL/min. Fractions (8 mL) containing ImiS 
were pooled and concentrated with an Amicon ultrafiltration cell equipped with a YM-10 membrane. Protein 
purity was ascertained by sodium dodecyl sulfate−polyacrylamide gel electrophoresis (SDS−PAGE). ImiS 
concentrations were determined using Beer's law and an extinction coefficient of 37 250 M-1 cm-1 (25). CoII-
substituted ImiS was prepared as previously described (12). 
Substrate Inhibition Studies.  
Substrate inhibition studies were carried out on recombinant ImiS using imipenem or meropenem as the 
substrate. Assays were conducted at 25 °C in 50 mM Tris at pH 7.0 on an HP 5480A diode array UV−vis 
spectrophotometer. Initial velocity versus imipenem concentration data were plotted and fitted with 
Michaelis−Menten equations assuming different modes of substrate inhibition (26). Imipenem and meropenem 
were gifts from Merck and Co. (Rahway, NJ) and Zeneca Pharmaceuticals (Wilmington, DE), respectively. 
Product Studies.  
Hydrolyzed products of imipenem were prepared by incubating 8 mM imipenem in 50 mM Tris at pH 7.0 with 
either 190 μM ImiS or 100 μM L1 (27), and the reactions were incubated on ice for 2 h. The enzymes were 
removed by using ultrafiltration (Centricon-10), and the resulting product containing solutions were analyzed at 
280 and 300 nm using UV−vis spectrophotometry to determine whether the solutions contained any protein or 
unhydrolyzed imipenem. The solutions were then flash-frozen in liquid nitrogen and lyophilized overnight. The 
products were analyzed with 1H nuclear magnetic resonance (NMR) spectroscopy (Bruker 500 MHz) or by liquid 
chromatography−mass spectrometry (LC−MS) (Bruker Esquire, ESI). The lyophilized products were then 
dissolved in 50 mM Tris at pH 7.0 and used in product inhibition studies with L1 (nitrocefin as the substrate) and 
ImiS (imipenem as the substrate). 
pH Dependence Studies.  
pH dependence studies were performed on recombinant ImiS over the pH range of 5.0−8.5 using a 
multicomponent buffer, MTEN. MTEN (25 mM MES, 25 mM Tris, 25 mM ethanolamine, and 100 mM NaCl) was 
used to minimize the effects of using different buffers over wide ranges of pH, and the NaCl was included to 
normalize the ionic strength effects in the buffer (28). The pH of the buffers was ascertained by using a pH-
meter. Steady-state kinetic assays were conducted at 25 °C in 50 mM Tris buffer at pH 7.0 on a HP 5480 diode 
array UV−vis spectrophotometer. Steady-state kinetic constants, KM and kcat, were determined by fitting initial 
velocity versus substrate concentration data directly to the Michaelis−Menten equation using Igor Pro version 
4.0.5.1 (Wavemetrics). The pH dependence data were fitted with Leonara (29); however, no pKa values above 
5.5 or below 8 were revealed with this software. 
Proton Inventories.  
Proton inventories were performed with ImiS in MTEN buffer at pH/pD 7.0 using imipenem as the substrate. 
Enzyme and substrate were incubated in the D2O-containing buffer for 30 min to allow for full proton−deuteron 
equilibration. Data were collected in buffers containing 0, 25, 50, 75, and 100% D2O [mole fraction of D2O (n) = 0, 
0.25, 0.5, 0.75, and 1.0]. The steady-state kinetic constant, kcat, was obtained as described above. The resulting 
kinetic constants were plotted versus their mole fraction D2O and fitted to the Gross−Butler equation for one 
(kcat 0[1 − n + (n(kD/kH))], two (kcat 0[1 − n + (n(kD/kH)][1 − n + (n(kD/kH)], and multiple (kcat 0[(kD/kH)n]) protons in 
flight models (30, 31). 
Generation and Characterization of K224T and N233S Mutants.  
Using the PAGE-purified oligonucleotides primers and the overexpression plasmid for ImiS (pET26b-ImiS) as the 
template, ImiS mutants were generated using the Quikchange site-directed mutagenesis kit according to the 
instructions of the manufacturer. The primers used for the mutagenesis studies were K224T forward, 
CTTTATggCAACTgCATCCTCACCgAGAAGCTgggCAACCTgAgCTTTgCC; K224T reverse, 
ggCAAAgCTCAggTTgCCCAgCTTCTCggTgAggATgCAgTTgCCATAAAg; N223S forward, 
gCCTTCACATCggCAAAgCTCAggCTgCCCAgCTTCTCCTTgAggAT; N223S reverse, 
ATCCTCAAggAgAAgCTgggCAgCCTgAgCTTTgCCgATgTgAAggC. DNA sequencing of the mutated imiS genes using T7 
forward (TAATACgACTCACTATAgg) and T7 reverse ( CgATCAATAACGAgTCgCC) as the primers was used to 
confirm the presence of the mutation and that no other unintended mutations were present in the genes. These 
DNA sequences were analyzed on the Perkin-Elmer ABI 3100 genetic analyzer. 
To test for the overexpression of mutants, the mutant plasmids were transformed into E. coli BL21(DE3) cells 
and small-scale cell cultures were used (32). Large-scale 4 L preparations were performed using the protocol 
described above for wild-type ImiS. ZnII-loaded samples of ImiS and ImiS mutants were made 100 μM in ZnII and 
incubated for 30 min on ice. The samples were then dialyzed versus 3 × 1 L of metal-free, 50 mM Tris at pH 7.0 
and 4 °C over a 6 h time period to remove any unbound ZnII. These ZnII-loaded samples of ImiS and ImiS mutants 
were diluted to a final enzyme concentration of 5−10 μM. The metal content of these samples was determined 
using a Varian Liberty 2 inductively coupled plasma spectrometer with atomic emission spectroscopy detection 
(ICP−AES). The final dialysis buffer was used as a blank. Calibration curves for all metals tested were based on at 
least three concentration replicates, and all calibration curves had correlation coefficients of 0.9950 or better. 
Emission lines were monitored at 213.856, 238.892, 324.754, 259.940, 257.610, and 231.604 nm, with the most 
intense emissions for zinc, cobalt, copper, iron, manganese, and nickel, respectively. Errors in metal content 
were reported as standard deviations (σn-1) of replicate samples. 
ZnII-loaded ImiS and ImiS mutants were dialyzed versus 3 × 2 L of 5 mM phosphate at pH 7.0 over 6 h. The 
samples were then diluted with the same buffer to a final concentration of approximately 75 μg/mL. Circular 
dichroism (CD) spectra were obtained on a JASCO J-810 CD spectropolarimeter, operating at 25 °C. CD spectra 
were analyzed for secondary structural content using the CONTIN simulation program at DICHROWEB 
(http://www.cryst.bbk.ac.uk/ cdweb/html/home.html) (33, 34). 
ZnII-loaded ImiS and ImiS mutants were diluted with metal-free, 50 mM Tris at pH 7.0 to a final concentration of 
2 μM. Fluorescence spectra were obtained at 25 °C using an excitation wavelength of 295 nm on a Perkin-Elmer 
LS55 luminescence spectrophotometer. 
Stopped-Flow Kinetic Studies.  
Hydrolysis of imipenem (10−350 μM) by ImiS (120 μM) in 50 mM Tris buffer at pH 7.0 and 2 °C was followed by 
electronic absorption at 300 nm and by 280 nm excited fluorescence emission at ≥320 nm (320 nm cutoff filter) 
on an Applied Photophysics SX18MV spectrophotometer. Time-dependent electronic absorption spectra of CoII-
substituted ImiS (500 μM) were collected using a photodiode array (PD.1, Applied Photophysics) upon the 
recation with 500 μM imipenem at 2 °C. Kinetic data were fitted to either single- or double-exponential 
equations using KinTekSim version 3.20 software (http://www.kintek-corp.com/). Stopped-flow fluorescence 
data were also globally fitted using Applied Photophysics PC ProK global analysis software. 
Kinetic Simulations.  
Kinetic simulations were conducted using KINSIM (35). The values for flux and integral tolerances were left as 
the default values of 0.02 and 1 × 10-6, respectively. 
Rapid Freeze Quench (RFQ) Electron Paramagnetic Resonance (EPR) Spectra.  
Samples for RFQ−EPR studies were generated using a modified Update Instruments (Madison, WI) RFQ system 
(21). The RFQ system was calibrated by comparing the development of a low-spin FeIII EPR signal and the 
disappearance of a high-spin FeIII EPR signal with the associated optical changes at 636 nm using stopped-flow 
spectrophotometry, upon mixing myoglobin with an excess of sodium azide. The shortest, total effective 
reaction time that could be achieved with the RFQ system was 10 ms. The initial concentrations of CoII-
substituted ImiS and imipenem were 1 and 5 mM, respectively. EPR spectra were recorded using a Bruker 
EleXsys E500 EPR spectrometer equipped with an Oxford Instruments ITC4 temperature controller and an ESR-
900 helium flow cryostat. Spectra were recorded at 12 K with 1 mW microwave power. A Bruker ER-4116DM 
cavity was used, with a resonant frequency of 9.63 GHz (in perpendicular mode), and 10 G (1 mT) field 
modulation at 100 kHz was employed. Computer simulations of EPR spectra were carried out using the matrix 
diagonalization program XSophe [Bruker Biopsin GmbH] (36), assuming a spin Hamiltonian H = βgBS + SDS + SAI, 
where S = 3/2 and D > 0 corresponds to an MS = |±1/2〉 ground-state Kramers' doublet. For CoII, generally D ≫ 
βgBS and the spectrum is therefore insensitive to the precise value of D (37); in this work, the arbitrary value D = 
50 cm-1 was used. The g tensor was assumed to have at least axial symmetry because this allows for a unique 
solution to the spin Hamiltonian in terms of the real g values, gz and gx,y (or g∥ and g⊥), and the rhombic 
distortion of the axial zero-field splitting, E/D (37). The relationship between the resonance positions, geff(x,y,z), 
and these parameters are described in detail elsewhere (38, 39). Line widths were simulated using a single-strain 
parameter for each of the principal orientations. Where simulations of spectra are shown that contain more 
than one species, spectra that could be well-simulated assuming a single set of spin Hamiltonian parameters 
were used as basis spectra and linear combinations of two (and no more than two) basis spectra were used to 
model the spectra collected after reaction times, intermediate between those after which the basis spectra 
were recorded. Contributions of the individual species are estimated as ±5% of the total spins. 
Results 
Substrate Inhibition.  
Many enzymes conform to Michaelis−Menten kinetics over a limited range of substrate concentrations but 
deviate at higher substrate concentrations (40). Steady-state kinetic studies with ImiS and using imipenem or 
meropenem resulted in Michaelis−Menten plots that indicate significant substrate inhibition (Figure 1). Several 
substrate inhibition models [competitive, noncompetitive, etc. (26)] were tested to fit the observed steady-state 
kinetic data, and a model defined by uncompetitive substrate inhibition was the model that best-fitted the data 
(line in Figure 1). 
 
Figure 1 Michaelis−Menten plot of imipenem hydrolysis by ImiS in 50 mM Tris at pH 7.0 and 25 °C. The data 
were fitted to a Michaelis−Menten equation with uncompetitive substrate inhibition (26). 
 
Product Inhibition Studies.  
The recent crystal structure of CphA showed a unique bicyclic “intermediate” in the active site of the enzyme 
that is formed by the attack of the invariant hydroxyl group of the 6‘ substituent of biapenem (and other 
carbapenems) on the 3‘ carbon of the five-membered ring (11). Garau et al. argued that the formation of the 
second ring in the product occurs after C−N bond cleavage (11). To ascertain whether this bicyclic, hydrolyzed 
carbapenem is catalytically competent, we hydrolyzed imipenem with ImiS and with L1. L1 and ImiS were 
removed from the solutions by ultrafiltration, and the products were analyzed with 1H NMR spectroscopy and 
LC−MS. There were no differences in the mass spectra or the NMR spectra of the two products. Neither product 
absorbed in the UV−vis region about 280 nm. 
Therefore, the ImiS- and L1-generated products were used in product inhibition studies. The ImiS-generated 
product inhibited ImiS with a Ki of 53 ± 5 μM and inhibited L1 with a Ki of 615 ± 50 μM. The L1-generated 
product inhibited ImiS with a Ki of 4 ± 1 mM and inhibited L1 with a Ki of 2 ± 1 mM. Clearly, the ImiS-generated 
product is distinct from the L1-generated product. 
pH Dependence Studies.  
pH dependence kinetic studies can be used to probe for groups with ionizable protons associated on the free 
enzyme, free substrate, or enzyme−substrate complex (40). In pH dependence studies on ZnII-containing ImiS, a 
relatively narrow pH range of 5.0−8.5 was used because ImiS precipitated at pH values below 5.0 and above 8.5. 
A multicomponent buffer, MTEN (28), was used to minimize buffer and ionic strength effects. The log kcat and 
log(kcat/KM) versus pH plots (Figure 2) for hydrolysis of imipenem by ZnII-containing ImiS were fitted with Leonara 
(29); however, no pKa values above 5.5 or below 8.0 were revealed. Similar results have been reported for the 
dinuclear ZnII-containing β-lactamases L1 and CcrA (18, 41). pH dependence plots for CoII-substituted ImiS with 
imipenem also did not reveal any inflection points (data not shown). 
 
Figure 2 pH dependence plots of log kcat (·) and log kcat/KM (▪) for the hydrolysis of imipenem by ImiS in MTEN 
buffer. The data points represent average values from at least three trials. Error bars represent the standard 
deviation of multiple trials. 
 
Solvent Isotope Studies.  
Solvent isotope studies have been extensively used in the literature to probe reaction mechanisms of enzymes, 
specifically to identify any rate-limiting proton transfers (31). The hydrolysis of imipenem by ImiS yielded a 
solvent isotope effect (kH/kD) of 1.7 ± 0.2, suggesting a proton transfer during a nucleophilic reaction. A proton 
inventory of ImiS yielded a kcat versus mole fraction of D2O that was best-fitted to a multiple proton in flight 
model (Figure 3); however, we cannot unambiguously rule out the one or two proton in flight models (30). 
Similar proton inventories have been reported for dinuclear ZnII-containing L1 and CcrA (28, 41). 
 
Figure 3 Proton inventory of imipenem hydrolysis by ImiS. Data points represent averages of at least three trials, 
and error bars are standard deviations. The data were fitted to single proton (···), two proton ( ), and multiple 
proton in flight (-·-) models (30). 
 
K224T and N233S Mutants of ImiS.  
A lysine is located at position 224 in all sequenced MβLs except in L1 from Stenotrophomonas maltophilia (6). 
Lys224 has been proposed to be involved in substrate binding via electrostatic interactions with the invariant 
carboxylate group of the β-lactam-containing antibiotics (11, 42, 43). To test this hypothesis, Lys224 was 
mutated to a threonine using site-directed mutagenesis. Bordo and Argos have reported that threonine is the 
“safest” substitution in mutagenesis studies for exposed lysines (44). Small-scale cultures were used to show 
that the K224T mutant could be overexpressed and purified at levels comparable to wild-type ImiS. CD and 
fluorescence spectra of the K224T mutant were similar to those of wild-type ImiS (data not shown), suggesting 
that the point mutation does not result in large structural changes in the enzyme. 
Metal analyses on as-isolated and ZnII-loaded K224T demonstrated that the mutant binds 0.80 and 0.78 equiv of 
ZnII, respectively, which is similar to the metal content of wild-type ImiS (Table 1). Steady-state kinetics revealed 
that this mutant exhibited a 16-fold drop in kcat and a 4-fold increase in KM when using imipenem as a substrate 
(Table 1). In studies using meropenem as the substrate, the K224T mutant exhibited no change in KM and a 740-
fold decrease in kcat (Table 1). 













wild type 350 ± 15 100 ± 10 296 ± 20 308 ± 55 0.90 ± 0.06 0.85 ± 0.06 
K224T 17 ± 3 208 ± 90 0.67 ± 0.07 136 ± 30 0.80 ± 0.07 0.78 ± 0.15 
N233S 303 ± 27 109 ± 22 270 ± 28 151 ± 33 0.77 ± 0.08 0.90 ± 0.08 
a Steady-state kinetic constants and metal content were determined on at least three different preparations of 
the enzymes. Steady-state kinetic studies were conducted in 50 mM Tris at pH 7.0 and 25 °C.b ZnII-loaded 
samples were prepared by incubating the as-isolated enzymes with 100 μM ZnII for 30 min and dialyzed 3 times 
versus 1 L of 50 mM Tris at pH 7.0 for 2 h each. 
 
An asparagine is located at position 233 in all MβLs except L1 from S. maltophilia (subclass B3) (45), BlaB 
(subclass B1) (46), and IND-1 from Chryseobacterium species (subclass B1) (47). The N233S mutant could be 
overexpressed and purified at levels comparable to that of wild-type ImiS. This mutant also exhibited CD and 
fluorescence spectra similar to those of wild-type ImiS (25), suggesting that the point mutation did not cause a 
change in the structure of the enzyme. Metal analyses revealed that as-isolated and ZnII- loaded N233S bound 
0.77 and 0.99 equiv of ZnII, respectively (Table 1). Steady-state kinetics revealed that the N233S mutant 
exhibited steady-state kinetic constants similar to those of wild-type ImiS (Table 1). 
Stopped-Flow Kinetic Studies.  
In initial stopped-flow UV−vis studies, we reacted CoII-substituted ImiS with imipenem and we monitored the 
reaction using diode array detection, particularly in the 500−650 nm region of the spectra, in an effort to probe 
the ligand field transitions of high-spin CoII during the course of the reaction. In all of the experiments that we 
conducted, there were no observable changes in the intensities of the ligand field bands. Therefore, we chose to 
monitor the change in absorbance of the substrate during the course of the reaction. The rate of imipenem 
hydrolysis, monitored by stopped-flow spectrophotometry (Figure 4), was a complex function of the 
concentration of imipenem and exhibited uncompetitive substrate inhibition (Figure 1). A single-exponential fit 
to the single-turnover progress curve with 100 μM imipenem returned a turnover rate of 97 s-1 at 2 °C. 
 
Figure 4 Stopped-flow UV−vis data (data points) collected at 300 nm for the reaction of 120 μM ImiS with 100 
μM imipenem in 50 mM Tris buffer at pH 7.0 and 2 °C. The solid line is the simulated progress curve generated 
by KINSIM when using the kinetic mechanism in Scheme 1 and the rate constants in Table 2. 
 
Single-turnover (100 μM imipenem/meropenem and 120 μM ImiS) reactions were also probed with stopped-
flow fluorescence studies, which monitor tryptophan fluorescence of the enzyme during catalysis. The resulting 
stopped-flow fluorescence time courses were biphasic and showed a substantial quenching of fluorescence over 
the first 10 ms of the reaction, followed by a relatively slow regain to baseline levels over the subsequent 45 ms 
of the reaction. The stopped-flow fluorescence data were fitted with a double-exponential equation, which 
yielded a rate of 160 ± 4 s-1 for the initial quenching phase and a rate of 98 ± 1 s-1 for the slower fluorescence 
regain phase (Figure 5). Additional experiments were conducted at higher substrate and lower ImiS 
concentrations. However, as with the stopped-flow UV−vis studies, the rates of fluorescence quench and regain 
were lower at substrate concentrations > 200 μM. 
 
Figure 5 Stopped-flow fluorescence data (data points) of 120 μM ImiS reacted with 100 μM imipenem in 50 mM 
Tris at pH 7.0 and 2 °C. The data points show time dependence of the fluorescence emission at 320 nm after 
excitation at 280 nm. The solid line is the simulated progress curve generated by KINSIM when using the kinetic 
mechanism in Scheme 1 and the rate constants in Table 2. 
 
Global Fittings and KINSIM Simulations.  
Using previously reported kinetic mechanisms (17, 40, 48) and PC ProK global-fitting software, the stopped-flow 
fluorescence data were fitted. The simple Michaelis−Menten mechanism was tested first, and more complicated 
mechanisms were subsequently tested. The simplest mechanism that sufficiently fitted the data is shown in 
Scheme 1; this mechanism was previously proposed for dinuclear ZnII-containing MβL L1 from S. 
maltophilia when reacted with meropenem or cefaclor (48) (Table 2). Using the rate constants (Table 2), the 
mechanism in Scheme 1, and KINSIM (35), we could suitably simulate the stopped-flow fluorescence and UV−vis 
data (lines in Figures 4 and 5). The global fittings and kinetic simulations show that the rate constants 
determined with single-turnover experiments are equal to k5 and k7. This scenario supports our analyses that the 
second and third steps (k4 and k6, Scheme 1) of the mechanism are essentially irreversible. 
 
Scheme 1 









a Substrate used in the stopped-flow studies was imipenem. Data were fitted with Applied Photophysics PC ProK 
global-fitting software using the mechanism in Scheme 1. The reported uncertainties represent standard errors 
as determined by the ProK software (nonlinear Marquardt−Levenberg algorithm). 
 
The values obtained from the global fittings (Table 2) were used to calculate steady-state parameters according 
to kcat = (k3)(k5)(k7)/(k5)(k7) + (k3)(k7) + (k3)(k5) and KM = kcat{(k2 + k3)/(k1)(k3)}. The theoretical steady-state kinetic 
constants are kcat = 58 s-1 and KM = 39 μM. The theoretical values of kcat and KM are within a factor of 3 of the 
experimentally determined values at 2 °C:  kcat = 130 ± 30 s-1 and KM = 90 ± 50 μM. 
RFQ−EPR Studies.  
The EPR spectrum of CoII-substituted ImiS is shown in Figure 6A and was simulated assuming a single 
paramagnetic species with S = 3/2, MS = |±1/2〉, gx,y = 2.25, gz = 2.31, and E/D = 0.076 (Figure 4B). No other 
CoII species were detected between 4 and 13 K, and at microwave powers up to 40 mW, an MS = |±3/2〉 signal 
that was evident in some preparations of ImiS upon addition of substoichiometric CoII (12) was not observed in 
the present work; this may be related to the higher pH employed (7.0 versus 6.5) and the known propensity of 
CoII to adopt higher coordination numbers when possible (49). Upon the reaction of ImiS with imipenem for 10 
ms, the spectrum (Figure 6C) had clearly changed and subtraction of the resting signal indicated the appearance 
of a rhombic signal (Figure 7A) for which only the two low-field resonances could be resolved. From the EPR 
spectrum after a 21 ms reaction time (Figure 6D), a second species (Figure 7B) could be clearly isolated by 
subtraction of the resting signal and was simulated (Figure 7C) using S = 3/2, MS = |±1/2〉, gx,y = 2.24, gz = 
2.18, E/D = 0.145, and Ay(59Co) = 40 G. It should be noted that, while the line shape was best-simulated including 
an unresolved hyperfine coupling on the lowest field feature (gy for MS = |±1/2〉 of S = 3/2), the experimental 
data only suggested three barely resolved hyperfine lines and the data were not of sufficient signal-to-noise to 
confirm a full hyperfine pattern by the use of higher derivatives. The “21 ms” experimental spectrum (Figure 6D) 
was well-modeled by the addition of the simulations of the resting signal, accounting for 94% of the spins, and 
the rhombic signal, accounting for 6%. It is not clear whether the rhombic signal after 10 ms is the same as that 
after 21 ms; while the two lower field resonances clearly coincide, the high-field gz resonance may be either 
broadened or shifted in the “10 ms” spectrum compared to the “21 ms” spectrum, perhaps indicating some very 
subtle structural differences. The EPR spectrum continued to change upon further reaction. The spectrum after 
32 ms (Figure 6F) was again composed of the resting and rhombic signals (Figures 6G and 7D), and after 73 ms 
(Figure 6E), the intensity of the rhombic signal was greater than that after 21 ms by a factor of about 1.6, 
corresponding to 10% of the total CoII. When rapid-freeze-quenched samples were thawed and refrozen after 2 
s, an EPR signal (Figure 6I) consisting of a 35% resting signal and 65% of a third distinct signal, the “product” 
signal, was observed. The product signal was isolated (Figure 7F) by subtraction of the resting signal from Figure 
6I and could be simulated (Figure 7G) assuming S = 3/2, MS = |±1/2〉, gx,y = 2.35, gz = 2.12, and E/D = 0.13. An 
enzyme-bound product signal was also observed in RFQ−EPR spectra of B3 MβL L1 (21). 
 
Figure 6 Trace A shows the resting EPR signal of CoII-substituted ImiS. Initial concentrations of ImiS and 
imipenem were 1 and 5 mM, respectively. Traces C, D, F, H, and I show the EPR spectra of CoII-substituted ImiS 
upon the reaction with imipenem for 10 ms at 2 °C (C), 21 ms at 2 °C (D), 32 ms at 2 °C (F), 73 ms at 2 °C (H), and 
2 s at 2 °C (I). Trace B is a computer simulation of trace A, assuming S = 3/2, MS = |±1/2〉, gx,y = 2.25, gz = 2.31, 
and E/D = 0.076. Traces E, G, and J are models for D, F, and I, respectively, and consist of (0.94 × A) + (0.06 × 
trace C of Figure 7) (E), (0.89 × A) + (0.11 × trace C of Figure 7) (F), and (0.45 × A) + (0.65 × trace C of Figure 7) (I). 
Experimental EPR spectra were recorded at 12 K with 1 mW microwave power at 9.63 GHz. A 10 G (1 mT) field 
modulation at 100 kHz was employed. 
 
 
Figure 7 Isolated species. Traces A, B, D, E, and F are the EPR difference spectra generated by subtraction of the 
resting signal (trace A of Figure 6) from those of ImiS upon the reaction with imipenem at 2 °C for 10 ms, 21 ms, 
32 ms, 73 ms, and 2 s, respectively. Traces C and G are the computer simulations of traces B and F, 
assuming S = 3/2, MS = |±1/2〉, gx,y = 2.24, gz = 2.18, E/D = 0.145, and Ay(59Co) = 40 G and S = 3/2, MS = |±1/2〉
, gx,y = 2.35, gz = 2.12, and E/D = 0.13. 
 
Discussion 
There have been many reports on the reaction mechanisms of dinuclear ZnII-containing MβLs (from subgroups 
B1 and B3). In studies using CcrA and L1 and nitrocefin as the substrate, a ring-opened, nitrogen anionic 
intermediate was identified and kinetic studies revealed that the protonation of this intermediate was rate-
limiting (17−20, 41). RFQ−EPR studies demonstrated that this intermediate yielded a novel EPR signal (21). A 
similar intermediate has not been observed in studies with Bacillus cereus β-lactamase II (50). Spencer and co-
workers later extended mechanistic studies on L1 using other substrates such as cefaclor and meropenem (48). 
Kinetic analyses revealed that β-lactam bond cleavage is rate-limiting with these substrates, and these authors 
hypothesized that the intermediate observed when nitrocefin is used as a substrate is unique to nitrocefin and 
due to the highly conjugated, bis-nitro-substituted styryl substituent (48). Therefore, the reaction mechanisms 
of the B1 and B3 MβLs are becoming clearer. In contrast, there is little mechanistic information [except that 
inferred by a recent crystal structure on CphA (11) and that proposed on the basis of very recent computational 
studies on CphA (51, 52)] on any of the mononuclear ZnII-containing B2 MβLs. 
Many enzymes, including L1 (27), exhibit substrate inhibition at high substrate concentrations (29); however, the 
concentrations of substrate required to inhibit ImiS are relatively low (>200 μM). Analysis of the steady-state 
kinetic data demonstrates that the observed substrate inhibition in ImiS is uncompetitive (Figure 1), which 
indicates that the inhibitory substrate molecule binds to the ES (or species derived from the ES) complex. With 
ImiS, it is possible that the substrate could bind with the β-lactam carbonyl or the β-lactam nitrogen coordinated 
to the metal ion, with one binding mode being the catalytically active mode and one mode describing an 
inhibited enzyme. The scenario would be expected to result in competitive substrate inhibition. It has been 
proposed for the B1 and B3 MβLs that there is a loop that extends over the active site that may play a role in 
catalysis by “clamping down” and activating the substrate during catalysis (42, 53, 54). In the case of CphA (and 
presumably ImiS), there is an α helix (α3) that is located where this loop is in other enzymes (11). It is possible 
that a second molecule of the substrate could bind to ES and prevent this α helix from “clamping down” on the 
substrate. Further studies are required to better understand substrate inhibition in ImiS. 
Our first efforts to probe the mechanism used pH dependence and solvent isotope studies. As previously 
reported for L1 and CcrA (18, 28, 41), there are no apparent inflection points in the pH dependence plots. With 
L1 and CcrA, it was argued that the pKa of the bridging solvent group was much lower than 5, as a result of 
bridging two divalent ZnII ions. On the basis of extensive literature precedents on ZnII hydrolases (55−60), it is 
possible that the ZnII in ImiS in conjunction with Asp120 could generate a hydroxide that has a pKa < 5. However, 
recent computational studies (52), along with predictions from the crystallographic studies (11), suggest that the 
nucleophile in CphA is not generated by ZnII and that the nucleophile is generated by assistance of His118 and 
Asp120 (11) or solely by Asp120 (52). In addition, our RFQ−EPR studies suggest that there are only five ligands 
bound to the metal during catalysis, and these ligands are most likely three amino acid residues (Asp120, 
Cys221, and His263) and two points of attachment from the substrate (see below) (11). If in fact the reactive 
nucleophile is generated without the direct coordination to the metal ion, we hypothesize that both Asp120 and 
His118 participate in the generation of this nucleophile and that the pKa of this solvent molecule is atypically 
low. 
ImiS exhibited a solvent isotope effect that was very similar to that of dinuclear ZnII-containing L1 and CcrA (28, 
41); however, it is possible that there are >1 rate-significant protons in flight for ImiS. These data demonstrate 
that there is a rate-significant proton transfer in the reaction catalyzed by ImiS (30). Given that the rate-limiting 
step is most likely C−N bond cleavage (see below), one potentially important proton transfer could be to the ring 
nitrogen in the product. It is also possible that a proton transfer from the solvent molecule to generate the 
putative nucleophile could explain why multiple, rate-limiting proton transfers are possible with ImiS. 
The roles of Lys224 and Asn233 were probed using site-directed mutagenesis. Several groups have 
demonstrated that Lys224 is involved in substrate binding to several of the dinuclear-ZnII-containing MβLs 
(28, 42, 43, 61−64. In fact, the recent structure of CphA bound to product suggests that Lys224 interacts with the 
3‘ carboxylate on the substrate (11), and computational studies support a role of Lys224 in substrate binding 
(51). In contrast, our studies on the K224T mutant indicate that Lys224 is involved with catalysis, suggesting that 
the orientation of the 3‘ carboxylate is catalytically important. Crystallographic and computational studies 
suggested a role of the backbone amide of Asn233 in forming a hydrogen bond with the 3‘ carboxylate on the 
substrate (11, 51), and computational studies additionally suggested that the side-chain amide of Asn233 
hydrogen bonds with the β-lactam carbonyl on the substrate (52). Our mutagenesis studies demonstrate that 
the side chain of Asn233 is not involved in substrate binding or catalysis, which supports the former prediction 
but not the latter. 
Stopped-flow fluorescence and UV−vis studies were used next to probe the mechanism of ImiS. Stopped-flow 
fluorescence traces were similar in appearance to those of L1 (32, 48). The fluorescence properties of L1 are due 
to a single Trp (Trp37), which is located in close proximity to the dinuclear ZnII site (22). It is likely that the 
fluorescence changes upon substrate binding to ImiS are also due to a single tryptophan, possibly Trp87, which 
lies near the putative substrate-binding site and within 10 Å of ZnII in CphA (11). Stopped-flow fluorescence 
studies of 120 μM ImiS with 100 μM imipenem (or meropenem) resulted in a rapid decrease in fluorescence 
(kobs = 160 s-1) and a relatively slow regain in fluorescence (kobs = 98 s-1). Stopped-flow UV−vis studies, which 
monitored the hydrolysis of the β-lactam bond in the substrate (48), showed a rapid decrease in absorbance 
that was best-fitted with a single-exponential equation yielding a kobs = 97 s-1. As previously suggested for L1 
(48), the regain of fluorescence because of substrate loss and the loss of absorbance are due to β-lactam 
hydrolysis in ImiS, and this step is probably the rate-determining step. 
In an effort to offer a minimal kinetic mechanism that describes the data, global analyses and KINSIM were used 
to test several different kinetic mechanisms. The single-turnover data of ImiS were best-fitted/simulated using 
the kinetic mechanism and rate constants shown in Scheme 1 and Table 2, respectively. The minimal kinetic 
mechanism of ImiS shown in Scheme 1 is very similar to that of L1 (48) and suggests that the rate-limiting step is 
β-lactam hydrolysis. This mechanism also suggests the existence of a second ES complex (ES* in Scheme 1). The 
absence of ES* in our global analyses and KINSIM fits resulted in poor fits of the data. 
EPR spectroscopy of ImiS upon the reaction with imipenem identified two new imipenem-dependent signals 
because of isolated CoII. One, the rhombic signal, is indicative of a highly distorted geometry and suggestive of 5-
fold coordination of CoII. The partial resolution of 59Co hyperfine coupling of 40 G (4.3 × 10-3 cm-1) indicates a 
narrow intrinsic EPR line and is entirely consistent with such a structure, in which the rigid ligand environment 
necessary to constrain the distorted structure precludes large strains in g and/or the zero-field splitting 
parameters. From a structural basis, therefore, it is likely that the rhombic signal corresponds to either ES* or EI 
in the reaction proposed in Figure 8. In principle, the kinetic studies should provide further information as to 
which intermediate likely accumulates in sufficient amounts to be observed by EPR. In the case of ImiS, 
however, the situation is complicated by the substrate inhibition observed with imipenem. In the EPR 
experiment, the initial substrate concentration in the reaction mixture (after mixing) was 2.5 mM, and by 
extrapolation of Figure 1, the overall reaction rate may be expected to be of the order of 10% of that of the 
optimum rate. Uncompetitive inhibition, which best fits the data for ImiS and imipenem (Figure 1), implies 
further binding of imipenem to either ES, ES*, or EI, rather than a second, nonproductive mode of binding to the 
hitherto uncomplexed enzyme. Because the inhibition is not competitive, any molecule of imipenem to interact 
with the active site of ImiS will rapidly form ES and the imipenem pool will be initially depleted according 
to k1 and k2 and more slowly as fewer naked ImiS molecules are available. Because the enzyme and substrate are 
mixed in a 1:1 ratio and because k1 is high and Ki > Km, substrate inhibition will only be a factor during the mixing 
time, when local relative concentrations of imipenem may be higher than the eqiulibrium concentration. The 
mixing time is estimated to be ∼1 ms. This is comparable with the optimum rate of formation of ES*, and thus, 
the rate of formation of ES* from ES is unlikely to be impeded by more than a factor of 2 or so if this is indeed 
the step inhibited by excess substrate. Thus, ES* formation is likely to be complete between 1 and 2 ms after 
mixing. The formation of EI is expected after a further 7 ms, i.e., after 8−9 ms, and the rhombic species observed 
after 10 ms is, therefore, assignable to the EI complex. While the simplest interpretation of the EPR spectra 
beyond 10 ms invoked a single species (the rhombic) in addition to the resting species, the kinetics suggest an 
alternative explanation, that gz of the rhombic species is indeed unresolved, as in the signal isolated by the 
difference from the 10 ms reacted sample, and that the appearance of a resolved high-field feature in spectra 
recorded at longer reaction times is due to a contribution from the product species. While the EPR data are not 
of sufficient quality to differentiate these two explanations, the latter is entirely consistent with the kinetics, 
because the product complex would be expected to begin accumulating at around 18−19 ms. Thus, it is 
proposed that the rhombic species represents EI and the product species represents EP. 
 
Figure 8 Proposed reaction mechanism for ImiS. 
 
These data and previous crystallographic data (11) allow us to propose a reaction mechanism for ImiS (Figure 8). 
In the first step, the substrate binds to the active site replacing a water molecule. Initially, the carboxylate on the 
substrate interacts with Lys224 and ZnII; however, on the basis of kinetic simulations, we believe that a second 
ES complex (labeled ES*) forms. We postulate that the ZnII−substrate nitrogen interaction forms in ES*, 
generating a five-coordinate metal center. In our proposed mechanism, the nucleophile is generated by Asp120 
and His118 as previously proposed (11); this nucleophile attacks the β-lactam carbonyl, possibly activated by 
His196 (11), to generate a tetrahedral intermediate, which we have labeled EI. It is important to note that the 
recent computational study suggested that a tetrahedral intermediate does not form in the proposed 
mechanism of CphA (52), and our data cannot support nor refute this hypothesis. It is entirely possible that EI is 
in fact a ring-opened, unprotonated species, similar to that reported in studies with CcrA and L1 when reacted 
with nitrocefin (17, 19, 21). In either case, a proton must be transferred to the ring-opened nitrogen to generate 
the product. We have also included the structure of the EP complex in the mechanism because this species was 
detected by RFQ−EPR studies. The inclusion of an EP complex in our kinetic simulations did not affect the fits as 
long as the rate of formation of EP is much faster than the breakdown of EI. Our spectroscopic data do not 
support the previous hypothesis (52) of Asp120 releasing from the metal ion during catalysis, yielding a four-
coordinate intermediate. 
The recent crystal structure of CphA showed the presence of a bicyclic product of biapenem in the active site of 
the enzyme (11). The authors proposed that, after β-lactam bond cleavage, a substantial bond rotation occurs 
that allows for the proton on the hydroxyethyl substituent found on all carbapenems to transfer to the 2‘ 
position on the five-membered ring of the substrate and for the nucleophilic attack of the oxygen at the 3 
position. Because of steric constraints, it is clear that this cyclization occurs after C−N bond cleavage. Our 
product inhibition data strongly suggest that the bicyclic product is kinetically competent and is the final product 
of the reaction catalyzed by ImiS. 
The results described herein demonstrate that MβLs from each of the distinct subclasses share a common rate-
determining step, which is C−N bond cleavage. This fact suggests that inhibitors designed on this step will inhibit 
all MβLs, regardless of whether the enzymes are mono- or dinuclear ZnII-containing enzymes. 
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